<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04650000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P21917</UniProt_ID>
  <Seq_Length>467</Seq_Length>
  <Molecule_Weight>48361</Molecule_Weight>
  <KEGG_ID>hsa:1815</KEGG_ID>
  <Orthology_ID>K04147</Orthology_ID>
  <Function_Summary>Dopamine receptor responsible for neuronal signaling in the mesolimbic system of the brain, an area of the brain that regulates emotion and complex behavior. Its activity is mediated by G proteins which inhibit adenylyl cyclase.</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>3</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Dopamine D4 receptor</Alias>
      <Alias>D(2C) dopamine receptor</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with the neurotransmitter dopamine and activating adenylate cyclase via coupling to Gi/Go to initiate a change in cell activity.</Detail>
      <Keyword>Dopamine receptor activity, coupled via Gi/Go</Keyword>
      <Ontology_ID>GO:0001591</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Modulates the activity of a potassium channel.</Detail>
      <Keyword>Potassium channel regulator activity</Keyword>
      <Ontology_ID>GO:0015459</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins.</Detail>
      <Keyword>SH3 domain binding</Keyword>
      <Ontology_ID>GO:0017124</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.</Detail>
      <Keyword>Drug binding</Keyword>
      <Ontology_ID>GO:0008144</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with dopamine, a catecholamine neurotransmitter formed by aromatic-L-amino-acid decarboxylase from 3,4-dihydroxy-L-phenylalanine.</Detail>
      <Keyword>Dopamine binding</Keyword>
      <Ontology_ID>GO:0035240</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>194</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>332</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>329</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell.</Detail>
      <Keyword>Cellular calcium ion homeostasis</Keyword>
      <Ontology_ID>GO:0006874</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving dopamine.</Detail>
      <Keyword>Regulation of dopamine metabolic process</Keyword>
      <Ontology_ID>GO:0042053</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>An acute behavioral change resulting from a perceived external threat.</Detail>
      <Keyword>Behavioral fear response</Keyword>
      <Ontology_ID>GO:0001662</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, followed by inhibition of adenylyl cyclase and a subsequent decrease in the concentration of cyclic AMP.</Detail>
      <Keyword>Inhibition of adenylate cyclase activity by dopamine receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0007195</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The controlled release of arachidonic acid from a cell or group of cells.</Detail>
      <Keyword>Arachidonic acid secretion</Keyword>
      <Ontology_ID>GO:0050482</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the establishment or extent of the inhibitory postsynaptic potential (IPSP) which is a temporay decrease in postsynaptic potential due to the flow of negatively charged ions into the postsynaptic cell. The flow of ions that causes an IPSP is an inhibitory postsynaptic current (IPSC) and makes it more difficult for the neuron to fire an action potential.</Detail>
      <Keyword>Regulation of inhibitory postsynaptic membrane potential</Keyword>
      <Ontology_ID>GO:0060080</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of calcium ions via a voltage-gated calcium channel.</Detail>
      <Keyword>Negative regulation of calcium ion transport via voltage-gated calcium channel activity</Keyword>
      <Ontology_ID>GO:0051927</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a histamine stimulus. Histamine, the biogenic amine 2-(1H-imidazol-4-yl)ethanamine, is involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.</Detail>
      <Keyword>Response to histamine</Keyword>
      <Ontology_ID>GO:0034776</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Locomotory behavior in a fully developed and mature organism.</Detail>
      <Keyword>Adult locomotory behavior</Keyword>
      <Ontology_ID>GO:0008344</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in the behavior of an organism as a result of an ethanol stimulus.</Detail>
      <Keyword>Behavioral response to ethanol</Keyword>
      <Ontology_ID>GO:0048149</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Behavior that occurs predominantly, or only, in individuals that are part of a group.</Detail>
      <Keyword>Social behavior</Keyword>
      <Ontology_ID>GO:0035176</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a protein from a cell or group of cells.</Detail>
      <Keyword>Negative regulation of protein secretion</Keyword>
      <Ontology_ID>GO:0050709</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.</Detail>
      <Keyword>Dopamine metabolic process</Keyword>
      <Ontology_ID>GO:0042417</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the directed movement of dopamine into a cell.</Detail>
      <Keyword>Positive regulation of dopamine uptake</Keyword>
      <Ontology_ID>GO:0051586</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine.</Detail>
      <Keyword>Response to amphetamine</Keyword>
      <Ontology_ID>GO:0001975</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the activity of a sodium:hydrogen antiporter, which catalyzes the reaction: Na+(out) + H+(in) = Na+(in) + H+(out).</Detail>
      <Keyword>Positive regulation of sodium</Keyword>
      <Ontology_ID>GO:0032417</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme MAP kinase by phosphorylation by a MAPKK.</Detail>
      <Keyword>Activation of MAPK activity</Keyword>
      <Ontology_ID>GO:0000187</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in the behavior of an organism as a result of a cocaine stimulus.</Detail>
      <Keyword>Behavioral response to cocaine</Keyword>
      <Ontology_ID>GO:0048148</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <molStructure/>
  <Molecule_Seq>
    <Protein_Seq>MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPGLPPDPCGPDCAPPAPGLPQDPCGPDCAPPAPGLPRGPCGPDCAPPAPGLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC</Protein_Seq>
    <DNA_Seq>ATGGGGAACCGCAGCACCGCGGACGCGGACGGGCTGCTGGCTGGGCGCGGGCCGGCCGCGGGGGCATCTGCGGGGGCATCTGCGGGGCTGGCTGGGCAGGGCGCGGCGGCGCTGGTGGGGGGCGTGCTGCTCATCGGCGCGGTGCTCGCGGGGAACTCGCTCGTGTGCGTGAGCGTGGCCACCGAGCGCGCCCTGCAGACGCCCACCAACTCCTTCATCGTGAGCCTGGCGGCCGCCGACCTCCTCCTCGCTCTCCTGGTGCTGCCGCTCTTCGTCTACTCCGAGGTCCAGGGTGGCGCGTGGCTGCTGAGCCCCCGCCTGTGCGACGCCCTCATGGCCATGGACGTCATGCTGTGCACCGCCTCCATCTTCAACCTGTGCGCCATCAGCGTGGACAGGTTCGTGGCCGTGGCCGTGCCGCTGCGCTACAACCGGCAGGGTGGGAGCCGCCGGCAGCTGCTGCTCATCGGCGCCACGTGGCTGCTGTCCGCGGCGGTGGCGGCGCCCGTACTGTGCGGCCTCAACGACGTGCGCGGCCGCGACCCCGCCGTGTGCCGCCTGGAGGACCGCGACTACGTGGTCTACTCGTCCGTGTGCTCCTTCTTCCTACCCTGCCCGCTCATGCTGCTGCTCTACTGGGCCACGTTCCGCGGCCTGCAGCGCTGGGAGGTGGCACGTCGCGCCAAGCTGCACGGCCGCGCGCCCCGCCGACCCAGCGGCCCTGGCCCGCCTTCCCCCACGCCACCCGCGCCCCGCCTCCCCCAGGACCCCTGCGGCCCCGACTGTGCGCCCCCCGCGCCCGGCCTTCCCCGGGGTCCCTGCGGCCCCGACTGTGCGCCCGCCGCGCCCAGCCTCCCCCAGGACCCCTGCGGCCCCGACTGTGCGCCCCCCGCGCCCGGCCTCCCCCCGGACCCCTGCGGCTCCAACTGTGCTCCCCCCGACGCCGTCAGAGCCGCCGCGCTCCCACCCCAGACTCCACCGCAGACCCGCAGGAGGCGGCGTGCCAAGATCACCGGCCGGGAGCGCAAGGCCATGAGGGTCCTGCCGGTGGTGGTCGGGGCCTTCCTGCTGTGCTGGACGCCCTTCTTCGTGGTGCACATCACGCAGGCGCTGTGTCCTGCCTGCTCCGTGCCCCCGCGGCTGGTCAGCGCCGTCACCTGGCTGGGCTACGTCAACAGCGCCCTCAACCCCGTCATCTACACTGTCTTCAACGCCGAGTTCCGCAACGTCTTCCGCAAGGCCCTGCGTGCCTGCTGCTGAGCCGGGCACCCCCGGACGCCCCCCGGCCTGATGGCCAGGCCTCAGGGACCAAGGAGATGGGGAGGGCGCTTTTGTACGTTAATTAAACAAATTCCTTCCCAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to plasma membrane</CellLocal>
      <Ontology_ID>GO:0005887</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>DRD4</Gene_Name>
    <Gene_ID>1815</Gene_ID>
    <Genbank_ACCN>NM_000797</Genbank_ACCN>
    <Protein_ACCN>NP_000788</Protein_ACCN>
    <HGNC_ID>3025</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1815</Gene_URL>
    <UCSC_ID>uc001lqp.2</UCSC_ID>
    <EMBL_ID>ENSG00000069696</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Schizoaffective Disorder</Disease_Name>
      <Disease_Detail>Schizoaffective Disorder</Disease_Detail>
      <Disease_DB>SCH012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/schizoaffective_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Conduct Disorder</Disease_Name>
      <Disease_Detail>Conduct Disorder</Disease_Detail>
      <Disease_DB>CND002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/conduct_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Attention Deficit Hyperactivity Disorder</Disease_Name>
      <Disease_Detail>Attention Deficit Hyperactivity Disorder</Disease_Detail>
      <Disease_DB>ATT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/attention_deficit_hyperactivity_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Substance Dependence</Disease_Name>
      <Disease_Detail>Substance Dependence</Disease_Detail>
      <Disease_DB>SBS004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/substance_dependence?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Delusional Disorder</Disease_Name>
      <Disease_Detail>Delusional Disorder</Disease_Detail>
      <Disease_DB>DLS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/delusional_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Schizophrenia</Disease_Name>
      <Disease_Detail>Schizophrenia</Disease_Detail>
      <Disease_DB>SCH015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/schizophrenia?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Migraine Without Aura</Disease_Name>
      <Disease_Detail>Migraine</Disease_Detail>
      <Disease_DB>MGR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/migraine_without_aura?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Obesity</Disease_Name>
      <Disease_Detail>Obesity</Disease_Detail>
      <Disease_DB>OBS005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/obesity?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hyperprolactinemia</Disease_Name>
      <Disease_Detail>Hyperprolactinemia</Disease_Detail>
      <Disease_DB>HYP020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hyperprolactinemia?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Oppositional Defiant Disorder</Disease_Name>
      <Disease_Detail>Oppositional Defiant Disorder</Disease_Detail>
      <Disease_DB>OPP004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/oppositional_defiant_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chronic Tic Disorder</Disease_Name>
      <Disease_Detail>Chronic Tic Disorder</Disease_Detail>
      <Disease_DB>CHR056</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chronic_tic_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pathological Gambling</Disease_Name>
      <Disease_Detail>Pathological Gambling</Disease_Detail>
      <Disease_DB>PTH002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pathological_gambling?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Autonomic Nervous System Disease</Disease_Name>
      <Disease_Detail>Autonomic Nervous System Disease</Disease_Detail>
      <Disease_DB>ATN002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/autonomic_nervous_system_disease?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Obsessive-Compulsive Disorder</Disease_Name>
      <Disease_Detail>Obsessive-Compulsive Disorder</Disease_Detail>
      <Disease_DB>OBS002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/obsessive_compulsive_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parkinson's Disease</Disease_Name>
      <Disease_Detail>Parkinson's Disease</Disease_Detail>
      <Disease_DB>PRK002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parkinsons_disease?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tic Disorder</Disease_Name>
      <Disease_Detail>Tic Disorder</Disease_Detail>
      <Disease_DB>TCD001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tic_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Separation Anxiety Disorder</Disease_Name>
      <Disease_Detail>Separation Anxiety Disorder</Disease_Detail>
      <Disease_DB>SPR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/separation_anxiety_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Seasonal Affective Disorder</Disease_Name>
      <Disease_Detail>Seasonal Affective Disorder</Disease_Detail>
      <Disease_DB>SSN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/seasonal_affective_disorder?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Heroin Dependence</Disease_Name>
      <Disease_Detail>Heroin Dependence</Disease_Detail>
      <Disease_DB>HRN003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/heroin_dependence?search=DRD4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tardive Dyskinesia</Disease_Name>
      <Disease_Detail>Tardive Dyskinesia</Disease_Detail>
      <Disease_DB>TRD006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tardive_dyskinesia?search=DRD4#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of D(4) dopamine receptor</PDB_Title>
      <PDB_ID>ASD04650000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
      <Has_Ligand>No</Has_Ligand>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04728</Pathway_ID>
      <Pathway_Title>Dopaminergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00070007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00170297</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00170350</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>